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Abstract 
Background: A wide debate is ongoing regarding the role of cutaneous dysbiosis in the pathogenesis and evolution 
of difficult-to-treat chronic wounds. Nowadays, probiotic treatment considered as an useful tool to counteract dysbio-
sis but the evidence in regard to their therapeutic use in the setting of difficult-to-treat cutaneous ulcers is still poor.
Aim: clinical report: An 83-year-old woman suffering a critical limb ischemia and an infected difficult-to-treat ulcer-
ated cutaneous lesion of the right leg, was complementary treated with local application of a mixture of probiotic 
bacteria.
Methods: Microbiological and metabolomic analysis were conducted on wound swabs obtained before and after 
bacteriotherapy.
Results: During the treatment course, a progressive healing of the lesion was observed with microbiological 
resolution of the polymicrobial infection of the wound. Metabolomic analysis showed a significant difference in the 
local concentration of propionate, 2-hydroxyisovalerate, 2-oxoisocaproate, 2,3-butanediol, putrescine, thymine, and 
trimethylamine before and after bacteriotherapy.
Conclusion: The microbiological and metabolomic results seem to confirm the usefulness of complementary pro-
biotic treatment in difficult-to-treat infected wounds. Further investigations are needed to confirm these preliminary 
findings.
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Background
Wound healing is a multi-layered process consisting of 
sequential overlapping phases, involving soluble media-
tors, blood and parenchymal cells [1]. This process is 
intrinsically linked to immune cells response and inflam-
mation. In recent years, new insights in the pathogen-
esis of chronic wounds highlighted the importance of 
cutaneous microbiome and skin dysbiosis. Polymicrobial 
biofilm, which foster pathogenic microbial growth and 
disrupts the coordinated events involved wound healing, 
are highly abundant in chronic wounds and play a cru-
cial role in the pathogenesis of impaired cutaneous heal-
ing [2]. In addition, polymicrobial biofilms can impair the 
efficacy of antibiotic therapy, thus leading to its overuse 
and to the subsequent development of antimicrobial 
resistance (AMR). Certain probiotics have been demon-
strated to be active against pathogens through competi-
tion for survival resources as well as the production of 
organic acids and antimicrobial substances [3]. There-
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strategy to promote wound healing in subjects with skin 
lesions colonized or infected by multi drug resistant bac-
teria (MDR). Herein, we report a compassionate case of 
an 83  year old woman successfully treated with topical 
administration of probiotics for an ischemic and infected 
(polymicrobial infection: Klebsiella pneumonias, Entero-
coccus faecalis and Proteus mirabilis) chronic wound.
Clinical case
A 83-year-old woman affected by Critical Limb Ischemia 
(CLI) developed an ulcerated cutaneous lesion of the 
right leg, extended to the second and third finger of 
the homolateral foot. Her medical history showed type 
II diabetes mellitus, systemic arterial hypertension, 
ischemic heart disease (previous coronary artery bypass 
surgery) and atrial fibrillation; she was also an active ciga-
rette smoker (20 cigarettes/day for 40 years). On physical 
examination, the above mentioned cutaneous ulceration 
showed anterior and posterior necrotic eschars; moreo-
ver, acupressure provoked a lively tenderness and pain 
inhibited leg motility. Finally, bilateral femoral pulses 
were present while distal peripheral pulses were absent 
(popliteal, posterior tibial and pedidial artery). Ankle 
Brachial Index (ABI) was bilaterally not assessable.
On admission, blood exams showed C-reactive pro-
tein (CRP) 101,000 μg/L, erythrocyte sedimentation rate 
(ESR) 100  mm/h, hemoglobin (HGB) 8.0  g/dl, platelets 
count 454,000  μg/L, white blood cells count (WBC) 
12,800/μl, international normalized ratio (INR) 1.87, 
partial thromboplastin time (PTT) ratio 2.3. Surgical 
management consisted of recanalization and percuta-
neous transluminal angioplasty (PTA) with drug eluting 
balloon (DEB) ranger 5 × 100 mm in superficial femoral 
artery (SFA) and right popliteal artery, followed by sur-
gical curettage of necrotic forefoot injuries and amputa-
tion of the second toe of the right foot. The infectious 
diseases specialist recommended to start systemic anti-
biotic therapy with piperacillin/tazobactam 4.5  g I.V. 
every 8 h.
After 8 days, an improvement of inflammatory markers 
was observed, and antibiotic therapy was switched to oral 
minocycline100 mg (1 tablet every 12 h) for 15 days. The 
patient was discharged after a total of 21 days of hospital-
ization. At home, the patient underwent local dressing of 
wound and amputation margins with antiseptic compress 
solution twice a week after cleansing, furthermore a poly-
meric membrane  (PolyMem®-Ferries Mfg) was routinely 
applied.
36 days after hospital discharge, given the worsening 
of local condition with considerable increase in exuda-
tion, despite a 4 weeks course of antibiotic therapy with 
Amoxicillin (500 mg orally every 12 h) empirically pre-
scribed by the treating physician, the patient referred to 
our University Center. At the time of first observation, 
the wound appeared moist with abundant secretion and 
covered with fibrin. A wound swab was routinely per-
formed and confirmed the previous evidence of positiv-
ity for MDR K. pneumoniae, E. faecalis and P. mirabilis. 
Although the patient was afebrile, three blood cultures, 
that tested negative, were performed.
Give the multiple microorganisms present on the 
wound and the severely prostrated general conditions 
of the patient, it was decided to start medications with 
10% cutaneous-iodopovidone solution for topical use 
 (Poviderm® 10% Skin Solution). After 30  days, since 
no improvement of the wound was observed, systemic 
antibiotic treatment was suspended. In reason of the 
previous therapeutic failures, the possibility of treat-
ing the wound with a mixture of probiotics as a rescue 
therapy was considered; written informed consent was 
obtained and subsequently a mixture of probiotic bac-
teria (lyophilized powder sachets, each containing 100 
billion colony forming unit (CFU) of Lactobacillus plan-
tarum NCIBMB 43029 20% in weight, Lactobacillus 
acidophilus NCIBMB 43030 20% in weight and Strepto-
coccus thermophilus NCIMB 30438 40% in weight) (pro-
vided by Mendes SA, Lugano, Switzerland) was topically 
applied three times/week. Probiotic treatment was pro-
vided by Mendes SA, Lugano, Switzerland.
The conditions of the wound appeared stable after 
1 week of probiotic treatment. Following 2 weeks of 
treatment a modification in microbiological results and 
a slowly progressive healing of the lesion were noted. 
The wound pad tested negative for E. faecalis at day 48 
(12 days after the start of the probiotic treatment) and 
negative for K. pneumoniae and P. mirabilis at day 57 
(after 21 days of the topical probiotic treatment). In the 
initial phase of treatment, an entire probiotic sachet 
(100 billion CFU) was applied three times/week, while 
in subsequent period the applied amount was propor-
tional to the residual size of the wound. Systemic or 
topical antibiotic treatment was not administered dur-
ing the course of probiotics. The overall duration of 
probiotic application was 24 days (Fig. 1).
During the subsequent 90 days, a slow but complete 
wound healing was observed; PolyMem dressings were 
applied by the patient to improve comfort in reason of 
the fact that autonomous walking and other daily tasks 
were resumed. Furthermore, normalization of serum 
inflammatory markers (erythrocyte sedimentation rate 
(ESR) and CRP) was observed.
Materials and methods
Wound swabs, collected before and after bacteriother-
apy, were examined.
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Microbiological analyses
Swabs were collected according to the available guide-
lines, before probiotic administration and after 12, 21 
and 24  days of probiotic therapy [4]. After collection, 
wound swabs were plated on both aerobic and anaer-
obic plates and incubated at 37  °C for 24  h. Bacterial 
identification and antimicrobial susceptibility tests 
were performed with VITEK-2 system (bioMérieux, 
Italia Spa).
Until further analyses, bacteria were stored on cryo-
vial bead preservation system (Microbank; Pro-Lab 
Diagnostics, Richmond Hill, ON, Canada) at − 80  °C; 
the inoculum was prepared by spreading one cryovial 
bead on blood agar plate and incubating overnight at 
37 °C. One colony was resuspended in 3 ml of NaCl and 
then adjusted to a turbidity of 0.5 McFarland, corre-
sponding to ≈ 1.5 × 108 CFU/ml.
Antimicrobial activity of the probiotic mix was tested 
on K. pneumoniae, P. mirabilis and E. faecalis. Briefly, 
probiotic formulations were dissolved in 10  ml of 
M.R.S. broth. After 30 min of incubation at room tem-
perature, 450 µl of the obtained solution were added to 
450 µl of M.R.S. broth with a final volume of 900 µl (1:2 
dilution). A final bacterial inoculum of 5 × 105 CFU/ml 
was added to tubes containing twofold serial dilutions 
(1:2 to 1:256) of M.R.S. broth plus probiotic and incu-
bated at 37  °C for 24  h. Minimal bactericidal dilution 
(MBD) was defined as the lowest dilution that induced 
a ≥ 99.9% (i.e., ≥ 3-log10 CFU/ml) reduction of the ini-
tial bacterial count after 24 h of incubation.
Metabolomics
For metabolomic investigation, 250  mg of PolyMem 
sponges with absorbed exudates was added to 1  ml of 
bidistilled water and vortex mixed for 5 min. After cen-
trifugation at 18,630×g for 15  min at 4  °C, 0.7  ml of 
supernatant were added to 0.1  ml of a  D2O solution of 
3-(trimethylsilyl)-propionic-2,2,3,3-d4 acid (TSP) sodium 
salt 10  mmol/L, buffered at pH 7.00 ± 0.02 by means of 
1  M phosphate buffer, containing also  NaN3 2  mmol/l. 
TSP was employed as an Nuclear Magnetic Resonance 
(NMR) chemical-shift reference, while  NaN3 avoided 
microbial proliferation. After a second centrifugation at 
the above conditions, 1H-NMR spectra were recorded 
at 298  K with an AVANCE III spectrometer (Bruker, 
Milan, Italy), at a frequency of 600.13  MHz, equipped 
with Topspin software (Ver. 3.5). Following Zhu et  al. 
[5], the signals from broad resonances were suppressed 
by a CPMG-filter composed by 400 echoes with an echo 
time of 0.4  ms and a 180° pulse of 0.024  ms, for a total 
filter of 330 ms. The deuterium oxide residual signal was 
suppressed by means of pre-saturation. Topspin software 
was used to adjust the phase of each spectrum, while R 
computational language (R Development Core Team) 
was employed for any further spectra processing, mol-
ecules quantification and data mining step, by means of 
scripts developed in house as detailed elsewhere [6, 7]. 
Signals assignment was performed by comparing chemi-
cal shift and multiplicity with the Human Metabolome 
Database and the compounds library (Ver. 10) of Che-
nomx software (Chenomx Inc., Canada, Ver. 8.3) [8].
Fig. 1 Dynamics of clinical changes and healing of infected wound
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After identification and quantification, molecules 
underwent pathway enrichment analysis, by querying 
KEGG biochemical pathways database (https ://www.
genom e.jp) through MetaboAnalyst (ver. 4.0) web inter-
face (https ://www.metab oanal yst.ca) [9].
Results
Microbiological analyses
Prior to probiotic therapy, wound swab grew K. pneumo-
niae, P. mirabilis and E. faecalis whereas at day 12 only 
K. pneumoniae and P. mirabilis showed growth and at 
day 21 the wound swab did not show bacterial growth. 
Absence of bacterial growth was confirmed also at day 24 
after probiotic therapy. The in vitro MBD of the probiotic 
formulation against Klebsiella pneumoniae, Enterococcus 
faecalis and Proteus mirabilis, was 1:16, 1:16 and 1:64, 
respectively.
Metabolomics
Overall, 63 molecules were identified: seventeen of them 
showed a change in their initial concentration equal 
or greater than 30% after the treatment with probiotic. 
Proprionate, 2-hydroxyisovalerate, 2-oxoisocaproate, 
2,3-butanediol, putrescine, thymine, and trimethylamine 
showed the greatest differences in concentration between 
the time when the wound was infected and the time 
when it became sterile (Figs. 2 and 3).
Discussion
Chronic wounds represent a “silent epidemic” that affects 
a large fraction of the world population [5]. In developed 
countries, 1–2% of the population is estimated to experi-
ence a chronic wound during its lifetime [10]. Despite the 
fact that a variety of therapeutic modalities and multidis-
ciplinary approaches have been developed, antimicrobial 
treatments are often ineffective and impaired wound 
healing remains a major challenge for both health profes-
sionals and patients.
Wound healing is a natural biological multi-layered 
process that can be affected by many factors, among 
which the interaction of the wound with the skin micro-
flora is one of the most important [11]. At present, 19 
bacterial phyla and over 1000 bacterial species have been 
identified within the most superficial level of skin, includ-
ing in wounds [12, 13]. Systemic or topic antimicrobial 
treatments may reduce beneficial bacterial populations 
and contribute to the emergence of an antibiotic resistant 
flora, with detrimental effects on wound healing [14, 15].
In about 60% of chronic wounds [2], bacterial biofilm 
is associated with impaired wound healing. Biofilm is 
constituted by bacteria embedded in an exo-polymeric 
Fig. 2 Metabolomics investigation: 1H-NMR spectra of molecules obtained by wound swabs before (T0) and after (T2) probiotic administration
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substance consisting of polysaccharides, lipids, and pro-
teins [16]. This extracellular matrix acts as a physical 
barrier that protects the embedded bacteria from anti-
biotics as well as host defense mechanisms. At the same 
time, since space and resources are not unlimited, differ-
ent bacterial species are forced to develop the capabil-
ity to counteract proliferation of other microorganisms 
by secreting toxic metabolites or by interfering with 
competitors’ quorum-sensing [17–20]. This concept, 
known as ‘bacterial interference’, has been transposed 
to practice by administering alpha streptococci with the 
intent to reduce the recurrences of acute and secretory 
otitis media in children [21].
Probiotics are defined by the World Health Organiza-
tion as “live microorganisms which, when administered 
in adequate amounts, confer a health benefit to the host” 
Fig. 3 Pathway enrichment analysis on all the molecules quantified by 1H-NMR. The barplots report the concentrations of the molecules differing 
by more than 30% in connection to the treatment. Names without barplots report the observed molecules included in the same pathway, differing 
by less than 30%
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[22]. Bacteria with probiotic properties have been already 
reported to be beneficial in the management of diabetes, 
respiratory tract infections, gastro-intestinal disorders, 
and uro-genital infections [23–29]. Oral ingestion of pro-
biotics has also been reported to be advantageous in skin 
inflammatory diseases and chronic wounds [30].
To the knowledge of the authors, this is the first time 
that a probiotic formulation was applied topically on a 
chronic ischemic wound infected by three MDR bacteria.
Obviously, the probiotic treatment might exert its posi-
tive effects on wound healing not only by counteracting 
pathogenic bacteria proliferation as evidenced by the 
results of the in  vitro MBD against K. pneumoniae, E. 
faecalis and P. mirabilis, but also through modulation of 
host immune response (e.g. by inducing cytokine produc-
tion: tumor necrosis factor (TNF)-α, interferon (IFN)-γ, 
interleukin (IL)-4, IL-6, transforming growth factor 
(TGF)-β and matrix metalloproteinases (MMPs) [31]) 
and by stimulating keratinocyte proliferation and migra-
tion [32, 33].
Chronic wounds produce exudates containing high 
levels of proteases, i.e. metalloproteases and elastase, as 
well as reduced concentrations of tissue protease inhibi-
tors [34]. The unbalanced activity of proteases and their 
inhibitors leads to chronic degradation of the extracellu-
lar matrix with consequent release of “waste amino acid 
products”, which can be identified by metabolomic analy-
sis. In our patient, the 1H-NMR delineated that metabolic 
pattern of wound exudate drastically changed after the 
topical probiotic treatment. Seventeen molecules, out of 
the 63 overall identified, showed a change in their con-
centration of at least 30% after the treatment (Figs.  2 
and 3). In particular, proprionate, 2-hydroxyisovalerate, 
2-oxoisocaproate, 2,3-butanediol, putrescine, thymine, 
and trimethylamine significantly differed between the 
infected phase and sterile phase of the wound. Pathway 
enrichment analysis based on the molecules identified 
and quantified, suggested that three pathways were dif-
ferently expressed before and after the treatment (Fig. 3). 
By means of 1H-NMR, we could quantify 5 molecules 
pertaining to the pyrimidine metabolism and the concen-
tration of three of them, namely cytidine, thymine and 
malonate, was found to decrease by more than 30% in 
connection to the treatment. A similar decrease charac-
terized also lysine and N6-acetyllysine, two of the three 
molecules involved in lysine degradation that we were 
able to quantify. Finally, a decrease of more than 30% 
characterized also pyroglutamate and putrescine, two of 
the four molecules involved in glutathione metabolism 
that we could quantify. The differential expression of each 
of the three pathways seems to be connected to the mod-
ification in bacterial activity in connection to the resolu-
tion of infection.
Since lysine is an essential amino acid, the observed 
decreases of its free form in the wound exudate, which 
is not regulated endogenously, can be safely considered 
as a direct consequence of the reduced proteolysis activ-
ity locally exerted by bacteria, caused by the resolution of 
Proteus infection.
Circulating pyrimidine nucleobases are tightly regu-
lated by effective cells’ uptake mechanisms [35], in reason 
of this observation the lower concentration of cytidine 
and thymine upon infection resolution may reflect the 
restore of normal functionality of the cells surrounding 
the wound.
In addition to the three pathways identified, other 
metabolites quantified by 1H-NMR may be functionally 
related to pathogens proliferating in the infected wound 
of the reported case.
Liu et  al. demonstrated that l-serine, l-valine and 
l-leucine promote macrophage phagocytosis in K. pneu-
moniae lung infection, thus declining Klebsiella con-
centration and increasing host survival [36]. The high 
concentration of, bona fide, microbial related metabolites 
from branched chain amino acids (e.g. propionate [37]) 
in the infected wound as well as their conspicuous deple-
tion in the probiotic-treated and pathogen-eradicated 
healed-wound may indeed reflect infection resolution 
and reduced systemic stress. Moreover, a high reduc-
tion of 2-hydroxyisovalerate and 2-hydroxyisocaproate 
concentrations after the ulcer treatment with probiotics 
was also detected. These molecules are hydroxyderivate 
of the alpha-ketoacid catabolites respectively produced 
by transamination of valine and leucine [38, 39]. Valine 
and leucine catabolism may proceed toward propion-
ate synthesis or may shift to 2-hydroxyisovalerate and 
2-hydroxyisocaproate production. Marked increase in 
concentrations of branched-chain amino and 2-oxo 
acids may have toxic effects for the host, as systemically 
observed in maple syrup urine disease (MSUD) [40].
In the reported case, the massive decrease of 2,3-buten-
ediol in the second wound exudate collected may reflect 
the clearance of Klebsiella infection, as confirmed by 
microbiological analyses. K. pneumoniae, which is one 
of the most studied microorganisms for the large-scale 
production of this compound, has in fact an incred-
ible ability to metabolize various substrates to produce 
high amounts of 2,3-butenediol [41]. A further possible 
involvement of Klebsiella in conditioning the metabo-
lomic pattern we depicted in the infected wound is sug-
gested by the complementary concentration trend of 
glycerol, formate and succinate. K. pneumoniae is com-
monly used and observed in glycerol fermentation under 
mesophilic conditions [42]. According to its humectant 
properties, skin endogenous glycerol, which is produced 
in pilosebaceous units by triglycerides catabolism, plays 
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a key role in skin hydration maintenance [43]. Klebsiella 
may indeed use skin glycerol as energy source during 
skin wound infections. According to our data, eradicated 
Klebsiella infection is associated: (i) to glycerol detec-
tion, which was not obtained in infected exudate, and (ii) 
to a significant decrease of fumarate and succinate, both 
obtained by glycerol fermentation.
Polyamine putrescine is another product normally 
derived by amino acid that appeared drastically reduced 
after probiotic treatment. Putrescine plays a role in sev-
eral steps of bacterial growth and virulence. It is actually 
involved in biofilm formation, protection from oxidative 
and acid stress and escape from phagolysosomes [44–46]. 
Dead tissues are an ideal medium for anaerobic bacte-
ria such as Bacteroides fragilis, Bacteroides prevotella, 
Clostridium perfrigens and Fusobacterium nucleatum, 
which produce putrescine and cadaverine. Other bac-
teria, such as Klebsiella and Proteus, colonize these tis-
sues and contribute to wound smell [47]. Putrescine, 
which is produced from arginine by the combined activ-
ity of SpeA and SpeB proteins, has been reported to be 
a cell wall component in P. mirabilis, in which it is also 
known to play a crucial role in control of gene expression, 
swarming, and tissue colonization [48]. Most likely, the 
high presence of putrescine in the first exudate sample of 
our patient was related to the presence of a heterogene-
ous bacterial community, including both anaerobic and 
aerobic microorganisms even though the drastic reduc-
tion of putrescine and propionate in the second exudate 
is apparently imputed to the ongoing resolution of Pro-
teus infection.
The main limitation for this study is that it is a case 
report and therefore the results presented should be con-
sidered with extreme caution. Furthermore, a number of 
studies reported a variability in both microbial counts 
and isolates obtained from different parts of chronic 
wounds. In our case, the culture data (obtained from 
the center and the edge of the wound sampling) may 
have been influenced by the combination of these loca-
tions within one single swab. Finally, the data obtained 
with the probiotic mixture used for this patient are not 
automatically extendable to other probiotics and further 
studies are needed to better define the potential of the 
products used.
Conclusion
To summarize, the probiotic treatment resulted effec-
tive against the three bacteria species K. pneumonia, P. 
mirabilis and E. faecalis, which are notoriously difficult 
to eradicate from infected wounds. The metabolites iden-
tified by 1H-NMR in the infected wound exudate were 
considered to be consequent to the lysis of wound dead 
tissue and the formation of the exudate itself, which is 
at least in part determined by the activity of aerobic and 
anaerobic bacteria. The modifications of certain metabo-
lites were interpreted in the light of a drastic reduction 
in the bacterial load (as evidenced by clinical microbio-
logical analysis) as well as a consequence of generalized 
improvement of the wound.
Based on the promising results here discussed, clinical 
trials should be conducted to confirm the benefits of top-
ical probiotic treatment for the management of chronic 
wound healing.
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